LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Allogene Therapeutics and Millions of Other Companies

Sign up for full access to Allogene Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Loading spinner
Gathering insights about Allogene Therapeutics…

Similar companies to Allogene Therapeutics

✕

Access Insights for Allogene Therapeutics and Millions of Other Companies

Sign up for full access to Allogene Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Allogene Therapeutics Tech Stack

Allogene Therapeutics uses 8 technology products and services including Databricks, OneTrust, Priority Hints, and more. Explore Allogene Therapeutics's tech stack below.

  • Databricks
    Big Data Processing
  • OneTrust
    Cookie Compliance
  • Priority Hints
    Performance
  • Hadoop
    Programming Languages
  • C#
    Programming Languages
  • New Relic
    Real User Monitoring
  • Autodesk
    Visualisation Software
  • Nginx
    Web Servers

Media & News

Allogene Therapeutics's Email Address Formats

Allogene Therapeutics uses at least 1 format(s):
Allogene Therapeutics Email FormatsExamplePercentage
First.Last@allogene.comJohn.Doe@allogene.com
97%
Last@allogene.comDoe@allogene.com
1%
Fir.Last@allogene.comJoh.Doe@allogene.com
1%
First@allogene.comJohn@allogene.com
1%

Frequently Asked Questions

Where is Allogene Therapeutics's headquarters located?

Minus sign iconPlus sign iconAllogene Therapeutics's main headquarters is located at 210 E Grand Ave South San Francisco, California 94080 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Allogene Therapeutics's phone number?

Minus sign iconPlus sign icon You can contact Allogene Therapeutics's main corporate office by phone at
✕

Access Insights for Allogene Therapeutics and Millions of Other Companies

Sign up for full access to Allogene Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-650-457-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Allogene Therapeutics's stock symbol?

Minus sign iconPlus sign iconAllogene Therapeutics is a publicly traded company; the company's stock symbol is ALLO.

What is Allogene Therapeutics's official website and social media links?

Minus sign iconPlus sign iconAllogene Therapeutics's official website is allogene.com and has social profiles on LinkedIn.

How much revenue does Allogene Therapeutics generate?

Minus sign iconPlus sign icon As of September 2024, Allogene Therapeutics's annual revenue reached $75M.

What is Allogene Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconAllogene Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Allogene Therapeutics have currently?

Minus sign iconPlus sign iconAs of September 2024, Allogene Therapeutics has approximately 277 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Technology Officer: T. M.Chief People Officer: S. L.Vice President Clinical Operations: A. K.. Explore Allogene Therapeutics's employee directory with LeadIQ.

What industry does Allogene Therapeutics belong to?

Minus sign iconPlus sign iconAllogene Therapeutics operates in the Biotechnology Research industry.

What technology does Allogene Therapeutics use?

Minus sign iconPlus sign iconAllogene Therapeutics's tech stack includes DatabricksOneTrustPriority HintsHadoopC#New RelicAutodeskNginx.

What is Allogene Therapeutics's email format?

Minus sign iconPlus sign iconAllogene Therapeutics's email format typically follows the pattern of . Find more Allogene Therapeutics email formats with LeadIQ.

How much funding has Allogene Therapeutics raised to date?

Minus sign iconPlus sign icon As of September 2024, Allogene Therapeutics has raised $110M in funding. The last funding round occurred on May 13, 2024 for $110M.

When was Allogene Therapeutics founded?

Minus sign iconPlus sign iconAllogene Therapeutics was founded in 2017.
Allogene Therapeutics

Allogene Therapeutics

Biotechnology ResearchCalifornia, United States201-500 Employees

Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) products for cancer and autoimmune disease. 

For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines

Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Allogene Therapeutics positions are accessible via the Allogene Careers page at www.allogene.com/careers.

✕

Access Insights for Allogene Therapeutics and Millions of Other Companies

Sign up for full access to Allogene Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
210 E Grand Ave South San Francisco, California 94080 US
Phone number
✕

Access Insights for Allogene Therapeutics and Millions of Other Companies

Sign up for full access to Allogene Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-650-457-****
Website
allogene.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ALLO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $110M

    Allogene Therapeutics has raised a total of $110M of funding over 5 rounds. Their latest funding round was raised on May 13, 2024 in the amount of $110M.

  • $50M$100M

    Allogene Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $110M

    Allogene Therapeutics has raised a total of $110M of funding over 5 rounds. Their latest funding round was raised on May 13, 2024 in the amount of $110M.

  • $50M$100M

    Allogene Therapeutics's revenue is in the range of $50M$100M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Allogene Therapeutics and Millions of Other Companies

Sign up for full access to Allogene Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.